Get the Stockscreener App
2.54
3.05%
-0.08
Tuhura Biosciences Inc stock is traded at $2.54, with a volume of 57,088.
It is down -3.05% in the last 24 hours and up +5.83% over the past month.
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.
See More
Previous Close:
$2.62
Open:
$2.7
24h Volume:
57,088
Relative Volume:
0.24
Market Cap:
$123.82M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+2.42%
1M Performance:
+5.83%
6M Performance:
-40.52%
1Y Performance:
+0.00%
1-Day Range:
$2.525
$2.7474
1-Week Range:
$2.37
$2.7474
52-Week Range:
$1.80
$7.20
Tuhura Biosciences Inc Stock (HURA) Company Profile
Name
Tuhura Biosciences Inc
Sector
Industry
Phone
813-875-6600
Address
10500 UNIVERSITY CENTER DR., TAMPA
Compare HURA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HURA
Tuhura Biosciences Inc
|
2.555 | 123.82M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.43 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.36 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.06 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
670.26 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
295.09 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Tuhura Biosciences Inc Stock (HURA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-03-25 | Initiated | H.C. Wainwright | Buy |
| Dec-19-24 | Initiated | Rodman & Renshaw | Buy |
| Nov-05-24 | Initiated | Maxim Group | Buy |
Tuhura Biosciences Inc Stock (HURA) Latest News
How many analysts rate TuHURA Biosciences Inc. as a “Buy”Exponential return rates - Jammu Links News
What institutional investors are buying TuHURA Biosciences Inc. stockCapitalize on fast-growing stocks today - Jammu Links News
Is TuHURA Biosciences Inc. a growth stock or a value stockHigh-octane financial growth - Jammu Links News
TuHURA Biosciences Inc. Stock Analysis and ForecastDiscover the fastest growing stocks today - Jammu Links News
Should I hold or sell TuHURA Biosciences Inc. stock in 2025Robust investment performance - Jammu Links News
How does TuHURA Biosciences Inc. compare to its industry peersGet high-impact stock recommendations now - Jammu Links News
What makes TuHURA Biosciences Inc. stock price move sharplyFree Advanced Stock Screener Access - Jammu Links News
How volatile is TuHURA Biosciences Inc. stock compared to the marketHigh-yield growth strategies - Jammu Links News
What is TuHURA Biosciences Inc. company’s growth strategyDiscover the fastest growing stocks today - Jammu Links News
How strong is TuHURA Biosciences Inc. company’s balance sheetDynamic portfolio growth - Jammu Links News
What are analysts’ price targets for TuHURA Biosciences Inc. in the next 12 monthsUnlock real-time trading signals for gains - Jammu Links News
Does TuHURA Biosciences Inc. stock perform well during market downturnsFree Stock Chart Pattern Guide - Jammu Links News
What catalysts could drive TuHURA Biosciences Inc. stock higher in 2025Navigate the market with precision tools - Jammu Links News
Is TuHURA Biosciences Inc. stock overvalued or undervaluedAccelerate your capital gains today - Jammu Links News
Published on: 2025-07-31 05:05:44 - Newser
TuHURA Biosciences Inc. stock daily chart insightsAI Model Forecasting Reversal and Breakout Zones - Newser
TuHURA Biosciences Inc. stock prediction for this weekScalable Portfolio Growth Suggestions Released - metal.it
How TuHURA Biosciences Inc. stock performs during market volatilityFree Chart Breakout Buy Signal Detection - Newser
TuHURA Biosciences Inc. Company’s Quarterly Earnings Growth: What the Numbers SayDay Trading Plan with Entry Risk Management - Newser
Will TuHURA Biosciences Inc. outperform the marketFree Market Surge Signal for Swing Traders - Newser
Moving Average Trends for TuHURA Biosciences Inc. Stock: What They IndicateRisk Managed Watchlist with Breakout Picks - Newser
Sector ETF performance correlation with TuHURA Biosciences Inc.Short-Term Growth Watch with Signal Prediction - Newser
TuHURA Biosciences Inc. Facing Inflection Point in Trend AnalysisConservative Entry for High Return Setup Backed - metal.it
How Resilient Is TuHURA Biosciences Inc. Stock During Economic DownturnsShort-Term AI-Based Stock Price Forecast - Newser
Real time breakdown of TuHURA Biosciences Inc. stock performanceAI Pattern Recognition and Trade Prediction - Newser
Order flow analysis tools used on TuHURA Biosciences Inc.Free Real-Time Analysis With Entry Targets - Newser
New Product Launches: Will They Boost TuHURA Biosciences Inc. Stock in 2025Real-Time Signal Tracking with Entry Level - Newser
Published on: 2025-07-29 04:58:15 - Newser
Leading vs lagging indicators on TuHURA Biosciences Inc. performanceFree High Yield Stocks With Buy Confirmation - Newser
What is the dividend policy of TuHURA Biosciences Inc. stockBreakthrough capital growth - Jammu Links News
Is it the right time to buy TuHURA Biosciences Inc. stockRapidly expanding wealth - Jammu Links News
Published on: 2025-07-28 04:11:10 - Newser
TuHURA Biosciences Inc. stock prediction for this week Free Breakout Momentum Picks With Protection - Newser
TuHURA Biosciences Inc. Stock Performance After Earnings: Historical InsightsCarefully Curated High Return Stocks - metal.it
Tuhura Biosciences Inc Stock (HURA) Financials Data
There is no financial data for Tuhura Biosciences Inc (HURA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.36%
1.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):